ArticleCancer2020

Aggressive myoepithelial carcinoma with EWSR1-POU5F1 fusion highly responsive to Ewing sarcoma combination chemotherapy.

Niraj ShenoyPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.